Technology assessment and the drug use process

American Journal of Managed Care

Volumn 5, Issue 2, 1999, Pages 220-229

  Solomon, David K ^a   Gourley, Dick R ^a   Brown, J Richard ^a   Gourley, Greta A ^a   Humma, Larisa M ^a  

^a UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DRUG;

ARTICLE; BIOMEDICAL TECHNOLOGY ASSESSMENT; CONSUMER; DRUG DELIVERY SYSTEM; DRUG FORMULARY; DRUG USE; EVIDENCE BASED MEDICINE; HEALTH PRACTITIONER; NURSE; PHARMACIST; PHARMACY AND THERAPEUTICS COMMITTEE; PHARMACY BENEFIT MANAGER; PHYSICIAN; PHYSICIAN ASSISTANT; PRACTICE GUIDELINE; PRIORITY JOURNAL;

ADVERTISING; DECISION MAKING, ORGANIZATIONAL; DRUG THERAPY; DRUG UTILIZATION REVIEW; EDUCATION, PHARMACY, CONTINUING; FORMULARIES; HUMANISM; HUMANS; INTERNET; MANAGED CARE PROGRAMS; PATIENT PARTICIPATION; PHARMACY AND THERAPEUTICS COMMITTEE; PRACTICE GUIDELINES; QUALITY OF LIFE; TECHNOLOGY ASSESSMENT, BIOMEDICAL; UNITED STATES;

EID: 0032996866     PISSN: 10880224     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. Mergers, acquisitions set a record despite 4th quarter slowdown. AHA News Jan 27, 1997:5.
2. New medicines in development for children and geriatrics - Survey, Pharmaceutical Research and Manufactures of America, 1998.
3. ASHP statement on the Formulary system. Practice Standards of ASHP. American Society of Health System Pharmacists: Washington, DC; 1998:5-6.
4. Horn SD, Sharkey PD, Gassaway, J. Managed care outcomes project: Study design, baseline patient characteristics and outcomes measures. Am J Managed Care 1996;2:237-247.
5. Horn SD, Sharkey PD, Tracy DM, Horn CE, James B, Goodwin F. Intended and unintended consequences of HMO cost containment strategies: Results from the managed care outcomes project. Am J Managed Care 1996;2:253-264.
6. Curtiss FR. Drug formularies provide a path to best care. Am J Health-Syst Pharm 1996;53:2201-2203.
7. Hayman JN, Crane VS. Multidisciplinary task force for controlling drug expenses. Am J Hosp Pharm 1993;50:2343-2347.
8. Cano S. Formularies in integrated health systems: Fallon healthcare system. Am J Health-Syst Pharm 1996;53:270-273.
9. Rizos AL, Levy E, Furnier J, Crowley K. Formularies in integrated health systems: Sharp healthcare. Am J Health-Syst Pharm 1996;53:274-278.
10. Osborne JA. Formularies in integrated health systems: Integris health. Am J Health-Syst Pharm 1996;53:278-280.
11. Novartis Pharmacy Benefit Report: Trends and Forecasts. East Hanover, NJ: Novartis Pharmaceutical Corporation; 1997.
12. Crane VS, Gonzalez ER, Hull BL. How to develop a proactive formulary system. Hosp Formulary 1994;29:700-710.
13. Navarro RP. Electronic formulary control. Med Interface 1997;10(8):74-76.
14. McCaffrey S, Nightingale CH. How to develop critical paths and prepare for other formulary management changes. Hosp Formulary 1994;29:628-635.
15. Weintraub M. Formulary review: An ongoing process. Pharm Ther 1990;15:847-848.
16. Hochla PK, Tauson VB. Pharmacy and therapeutics committee cost containment considerations. Arch Intern Med 1992;152:1773-1775.
17. Mutnick AH, Blayney JC. Impact of the pharmacy and therapeutic process on cost-effective initiatives within a tertiary care academic health center. Presented at: Midyear Clinical Meeting of American Society of Hospital Pharmacists; December 8, 1997; Atlanta, GA.
18. With patents expiring on big prescriptions, drug industry quakes. Wall Street Journal. August 12, 1997:A-1, A-6.
19. Navarro RP. Changing the rules: Coverage of nonprescription drugs. Med Interface 1997;10(2):84-86.
20. CibaGeneva Pharmacy Benefit Report Pocket Guide to the Pharmacy Benefit. Summit, NJ: CibaGeneva; 1996.
21. Gourley GA, Duncan DV. Patient satisfaction and quality of life: Humanistic outcomes. Am J Managed Care 1998;4:746-752.
22. Kozma CM, Reeder CE, Schulz RM. Economic, clinical, and humanistic outcomes: A planning model for pharmacoeconomic research. Clin Ther 1993;15:1121-1132.
23. American Society of Hospital Pharmacists. ASHP statement on the pharmacist's role with respect to drug delivery systems and administration devices. Am J Hosp Pharm 1993;50:1724-1725.
24. Matuszewski KA. A primer on the assessment of medical technologies. Pharm Pract Manage Q 1997;16(4):53-65.
25. Goodman CS. Healthcare technology assessment: Methods, framework, and role in policy making. Am J Managed Care 1998;4(special issue):SP225-SP234.
26. University HealthSystem Consortium. Technology Report: Implementation of Hospital-Based Technology Assessment. Oak Brook, IL: University HealthSystem Consortium; 1996.
27. Schiff GD, Rucker TD. Computerized prescribing: Building the electronic infrastructure for better medication usage. JAMA 1998;279:1024-1029.
28. Rivkin S. Opportunities and challenges of electronic physician prescribing technology. Med Interface 1997;10(8):77-83.
29. Pestotnik SL, Classen DC, Evans RS, Burke JP. Implementing antibiotic practice guidelines through computer-assisted decision support: Clinical and financial outcomes. Ann Intern Med 1996;124:884-890.
30. Joint Commission Readiness Planner: A focus on medication use. The Roche Skills Development Series for Improving Patient Care. 1996.[WHERE PUBLISHED?]
31. Poole TA. Pharmacy's transition to a proactive practice mode. Am J Health-Syst Pharm 1995;52:2821-2824.
32. Kennerly D, Hatwig C, Crane VS. Developing systematic, information-driven disease management interventions: A model. Formulary 1997;32:1232-1240.
33. Jadad AR, Gagliardi A. Rating health information on the internet. JAMA 1998;279:611-614.
34. Cohen J. Developing prescriptions with a personal touch. Science 1997;275:776.
35. Talley CR. Medication formularies in integrated systems [editorial]. Am J Health-Syst Pharm 1996;53:261.